Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Ethnopharmacol ; 148(3): 826-34, 2013 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-23721913

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: The roots and stem bark of Acanthopanax koreanum Nakai (Araliaceae), a well-known herbal medicine in Jeju Island, Korea, has been used as a tonic agent in treating stress-related states. Despite its popular application, the anti-anxiety or anti-depressive action of Acanthopanax koreanum is not yet known. AIM OF THE STUDY: This study aimed to determine the effects of Acanthopanax koreanum on stress-induced behavioral alterations such as anxiety and depression. MATERIALS AND METHODS: Mice in the acute stress group were exposed to immobilization stress for 2h followed by electric foot shocks (0.5 mA in 1 s duration with a 10 s inter-shock interval) for 2 min, while sub-chronically stressed mice were exposed to these stresses for 2 weeks, once per day. 70% ethanolic extract of Acanthopanax koreanum (EEAK) (25, 50, 100, or 200 mg/kg) was administered once or sub-chronically (for 2 weeks) 1h prior to stress induction. Anxiety- or depression-like behavioral changes were evaluated using the elevated plus-maze (EPM) test and the forced swimming test (FST) a day after the final stress induction. Corticosterone levels and spleen weight were measured after conducting all the behavioral assays. The numbers of BrdU- or DCX-immunopositive cells in the hippocampal region of sub-chronically stressed mice were measured 2 days after EEAK treatment. RESULTS: The percentage of time spent in the open arms was decreased in both the acutely and chronically stressed mice. In the FST, the immobility time was increased by only chronic stress, but not by acute stress. Acute or sub-chronic administration of EEAK significantly prevented the anxiety- or depression-like behavioral changes caused by stress. EEAK also attenuated stress-induced decrease and increase of spleen weight and corticosterone levels, respectively. Furthermore, the sub-chronic administration of EEAK (100 or 200 mg/kg, for 2 weeks) increased the number of BrdU-, doublecortin-, and neuropeptide Y-positive cells in the hippocampal region of the sub-chronically stressed mice. CONCLUSION: EEAK attenuated the behavioral and biochemical changes in acute or sub-chronic stressed mice. These results suggest the therapeutic potential of Acanthopanax koreanum for the treatment of stress-related neuropsychiatric disorders including anxiety disorders or major depressive disorder.


Asunto(s)
Ansiolíticos/uso terapéutico , Antidepresivos/uso terapéutico , Ansiedad/tratamiento farmacológico , Eleutherococcus , Extractos Vegetales/uso terapéutico , Animales , Ansiolíticos/farmacología , Antidepresivos/farmacología , Ansiedad/sangre , Ansiedad/fisiopatología , Conducta Animal/efectos de los fármacos , Corticosterona/sangre , Depresión/sangre , Depresión/tratamiento farmacológico , Depresión/fisiopatología , Proteína Doblecortina , Hipocampo/citología , Hipocampo/efectos de los fármacos , Masculino , Medicina Tradicional Coreana , Ratones , Ratones Endogámicos ICR , Neurogénesis/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Fitoterapia , Corteza de la Planta , Extractos Vegetales/farmacología , Raíces de Plantas , Restricción Física , Bazo/efectos de los fármacos , Bazo/patología , Estrés Psicológico/sangre , Estrés Psicológico/tratamiento farmacológico , Estrés Psicológico/fisiopatología
2.
Eur J Pharmacol ; 704(1-3): 70-7, 2013 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-23461850

RESUMEN

Salvianolic acid B (SalB) is a polyphenolic compound found in Salvia miltiorrhiza Bunge that has several anti-oxidative and anti-inflammatory effects. In the present study, we investigated whether SalB has neuroprotective effects in an amyloid ß (Aß) peptide-induced Alzheimer's disease mouse model. Mice were injected with Aß25-35 peptide intracerebroventricularly and were subsequently administered SalB once daily for 7 days. Subchronic SalB administration (10mg/kg) significantly ameliorated the Aß25-35 peptide-induced memory impairment in the passive avoidance task (P<0.05). SalB treatment also reduced the number of activated microglia and astrocytes that were observed during the inflammatory reaction after the administration of the Aß25-35 peptide. Moreover, SalB markedly reduced inducible nitric oxide synthase and cyclooxygenase-2 expression levels and thiobarbituric acid reactive substances, which were increased by the administration of the Aß25-35 peptide. Furthermore, SalB administration significantly rescued the Aß25-35 peptide-induced decrease of choline acetyltransferase and brain-derived neurotrophic factor protein levels. These results suggest that SalB exerts neuroprotective activity via anti-inflammatory and anti-oxidative effects and that SalB may be a potential candidate for Alzheimer's disease therapy.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Benzofuranos/uso terapéutico , Trastornos del Conocimiento/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/fisiopatología , Péptidos beta-Amiloides , Animales , Antiinflamatorios/farmacología , Reacción de Prevención/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Benzofuranos/farmacología , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Colina O-Acetiltransferasa/metabolismo , Trastornos del Conocimiento/metabolismo , Trastornos del Conocimiento/fisiopatología , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Hipocampo/citología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos ICR , Neuroglía/efectos de los fármacos , Neuroglía/metabolismo , Fármacos Neuroprotectores/farmacología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fragmentos de Péptidos
3.
Phytother Res ; 27(12): 1763-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23348874

RESUMEN

Prunella vulgaris var. lilacina is widely distributed in Korea, Japan, China, and Europe, and it has been traditionally used to treat inflammation or hypertension. In the present study, we investigated the effects of the ethanolic extract of the spikes of Prunella vulgaris var. lilacina (EEPV) on dizocilpine (MK-801)-induced schizophrenia-like phenotype behaviors such as the disruption of prepulse inhibition and attention deficits in mice. We also determined the effect of EEPV on MK-801-induced alterations in phosphorylated extracellular signal-regulated kinase, phosphorylated protein kinase B, phospho-glycogen synthase kinase 3-ß, and phosphorylated cAMP response element-binding protein levels in the cortex and hippocampus of mice. MK-801-induced prepulse inhibition deficits were ameliorated by the administration of EEPV, as shown in the acoustic startle response test. Furthermore, EEPV attenuated the MK-801-induced attention deficits in the water finding test. We also found that EEPV attenuated the increased phosphorylated extracellular signal-regulated kinase, phosphorylated protein kinase B, or phospho-glycogen synthase kinase 3-ß levels induced by MK-801 in the cortex but not in the hippocampus. These results suggest that EEPV could be useful for treating schizophrenia because EEPV ameliorates prepulse inhibition disruption and attention deficits induced by MK-801.


Asunto(s)
Atención/efectos de los fármacos , Extractos Vegetales/farmacología , Prunella/química , Reflejo de Sobresalto/efectos de los fármacos , Animales , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Maleato de Dizocilpina/farmacología , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Esquizofrenia/tratamiento farmacológico
4.
J Ethnopharmacol ; 143(2): 611-20, 2012 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-22846435

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Alzheimer's disease is a neurodegenerative disorder associated with cognitive impairment and cholinergic neuronal death. INM-176 is a standardized ethanolic extract of Angelica gigas Nakai that has been traditionally used in herbal medicine in China, Japan, and Korea to treat anemia or as a sedative. We investigated whether INM-176 exhibits anti-amnesic effects. MATERIALS AND METHODS: Memory impairment was induced by scopolamine, a cholinergic muscarinic receptor antagonist, or amyloid ß(1-42) (Aß(1-42)) protein. Anti-amnesic effects of INM-176 were measured by the passive avoidance and the Morris water maze tasks in mice. We also examined the effect of INM-176 on the acetylcholinesterase activity, as well as Aß(1-42) protein-induced astrogliosis or cholinergic neuronal loss in the brain. RESULTS: Scopolamine-induced cognitive dysfunction was significantly attenuated by a single or sub-chronic administration of INM-176 in the passive avoidance and the Morris water maze tasks. A single or sub-chronic administration of INM-176 also ameliorated memory impairments induced by Aß(1-42) protein. INM-176 inhibited acetylcholinesterase activity in the hippocampal tissue in vitro and ex vivo. In addition, INM-176 attenuated the Aß(1-42) protein-induced astrocyte activation in the hippocampus as well as cholinergic neuronal damage in the CA3 region of the hippocampus and the nucleus basalis of Meynert. CONCLUSION: These results suggest that the memory ameliorating effects of INM-176 on scopolamine- or Aß(1-42) protein-induced memory impairment are mediated, in part, via acetylcholinesterase inhibition and neuroprotective activities.


Asunto(s)
Angelica , Inhibidores de la Colinesterasa/uso terapéutico , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos de la Memoria/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Extractos Vegetales/uso terapéutico , Acetilcolinesterasa/metabolismo , Péptidos beta-Amiloides , Animales , Astrocitos/efectos de los fármacos , Astrocitos/fisiología , Reacción de Prevención/efectos de los fármacos , Inhibidores de la Colinesterasa/farmacología , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/fisiopatología , Etanol/química , Hipocampo/efectos de los fármacos , Hipocampo/patología , Hipocampo/fisiología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/fisiopatología , Ratones , Ratones Endogámicos ICR , Fármacos Neuroprotectores/farmacología , Fragmentos de Péptidos , Fitoterapia , Extractos Vegetales/farmacología , Escopolamina , Solventes/química
5.
J Environ Biol ; 29(5): 753-7, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19295077

RESUMEN

In the present study vermicomposting was carried out at three different concentrations of sago-sludge namely 50, 75 and 100% with an indigenous earthworm, Lampito mauritii for a period of 50 days. The fecundity of earthworm Lampito mauritii was found to be high in 50%. At the end of 50 days composting period. There were about 12 cocoons, 5 juveniles and 2 nonclitellates appeared at 50% sago-sludge concentration. The microbial analysis showed that after 40 days of composting their population stabilized and further increase in composting period did not increase their population size. Chemical analysis of Lampito mauritii worked substrates showed there is a step wise increase of nitrogen and phosphorus. The fold increase of phosphorus and nitrogen were found to be high for sago-sludge undergoing vermicomposting than the control. From the initial value of 1.8, 1.4 and 0.5 mg kg(-1) total nitrogen increased in a stepwise manner and reached a value of 5.8, 3.9 and 2.3 mg kg(-1), respectively for vermicomposting at 50, 75 and 100%. During composting the organic carbon decreased from its initial value of 56, 74 and 107 mg kg(-1) to 15, 25 and 58 mg kg(-1) for vermicomposting and 34, 45 and 72 mg kg(-1) for 50, 70 and 100% control, respectively. The results indicate that 50% and 75% concentration of sludge mixed with bedding material was ideal for the vermicomposting.


Asunto(s)
Residuos Industriales , Oligoquetos/metabolismo , Aguas del Alcantarillado/química , Animales , Biodegradación Ambiental , Carbono/análisis , Carbono/metabolismo , Nitrógeno/análisis , Nitrógeno/metabolismo , Fósforo/análisis , Fósforo/metabolismo , Aguas del Alcantarillado/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA